-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains Outperform on Immunome, Raises Price Target to $40

Benzinga·12/16/2025 14:27:50
语音播报
Evercore ISI Group analyst Cory Kasimov maintains Immunome (NASDAQ:IMNM) with a Outperform and raises the price target from $18 to $40.